Rohto Pharmaceutical Co.’s Managing Director, Corporate planning & administration. He is an energetic and dynamic leader with a progressive global vision for the growth and development of Rohto’s shareholder value. He has served as the President of Medicare Systems at Rohto Pharmaceutical Co. Ltd. , Managing Director of Tokyo Mitsubishi Toshin Toshi Komon K.K since June 2001, President and Representative Director at Mitsubishi Tokyo Wealth Management Shoken K.K since March 2002 and has been a Director at Rohto Pharmaceutical Co. Ltd. since June 6, 2008. He has led Rohto’s visionary long-term investments in R&D and has directed the continuous and dramatic growth of sales in recent years in spite of a weak economy in Japan. In the short term he has focused all activities on the goals of achieving further growth in Rohto’s operations and improving earnings by introducing value-added products and using the overseas network to expand operations. Strategically Rohto will continue to concentrate on sales of beauty care products and reinforce R&D capabilities, primarily at Rohto Research Village Kyoto, in order to develop and launch new products globally. Our mutual research collaboration will contribute to Rohto’s strategic goals, while enhancing the commercial, business development and market focus of Signum’s research priorities. We look forward to a productive and long-term relationship.